1 / 7

Rosacea Treatment Market Size, Growth | Industry Report, 2025

Rosacea Treatment Market Size, Share & Trends Analysis Report By Drug Class (Alpha Agonists, Antibiotics, Retinoids, Corticosteroids), By Mode of Administration (Topical, Oral), By Region, And Segment Forecasts, 2019 - 2025

Marsh
Download Presentation

Rosacea Treatment Market Size, Growth | Industry Report, 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rosacea Treatment Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc. “Rosacea Treatment Market Worth $2.6 Billion by 2025 | CAGR: 6.8%” The global Rosacea Treatment Market size is expected to reach USD 2.6 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.8% over the forecast period. Several factors such as an advanced formulations and high prevalence of the disease are forecasted to fuel the market growth. Rosacea affects more than 400 million people worldwide and the global incidence among adults is estimated at 5%. Less than 1.5 million patients seek treatment, making it a highly underdiagnosed condition. This disease has a higher incidence in women than men, with several studies claiming a possible association between rosacea and menopause. In the absence of an absolute cure, treatment options are largely focused on management of the disease. The market for rosacea treatment is majorly genericized due to multiple patent expiries, leading to a highly fragmented therapeutic landscape. Rosacea is an underdiagnosed condition and is frequently misdiagnosed as acne. Off-label use of therapeutics pose an intensely competitive space for rosacea-specific treatments. Topical therapies remain the mainstay for treatment. Topical products captured more than 60% market share in 2017. Although topical items are expected to maintain their lead over oral medicines through the forecast period, the market is witnessing a paradigm shift supported by the increasing inclination towards combination products. Therapeutic options available for rosacea treatment are antibiotics, alpha agonists, retinoids, immunosuppressants, corticosteroids, antihypertensive agents, and others. Antibiotics are prescribed for the first-line treatment, making them the dominant drug class in 2017-a trend expected to continue through 2025. Follow Us:

  2. The rosacea treatment market growth is supported by strong commercial sales from key products such as Rhofade, Mirvaso, Oracea, MetroGel, Noritate, and Finacea. Although increased penetration of generic drugs is a constraining factor, the impending launch of several promising pipeline products indicate an optimistic future for the global market. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/rosacea-treatment- market Further key findings from the report suggest: The topical drugs segment held over 65% market share in 2017. These drugs are generally prescribed as first-line treatments and are preferred over other options in terms of convenience and results • Alpha agonists is anticipated to be the fastest growing drug class, with a CAGR of over 8% during the forecast period • Geographically, North America and Europe are the leading regions as the disease tends to affect people with fair/light skin. Asia Pacific is anticipated to witness the fastest growth owing to improved economic and healthcare scenario • Key players operating in the rosacea treatment market include Bayer Schering AG; Bausch Health Companies Inc.; Foamix Pharmaceuticals; Nestlé S.A.; and Allergan Plc. • Grand View Research has segmented the global rosacea treatment market based on drug class, mode of administration, and region: Rosacea Treatment Drug Class Outlook (Revenue, USD Million, 2014 - 2025) Antibiotics • Alpha agonists • Retinoids • Corticosteroids • Immunosuppressants • Antihypertensive Agents • Others • Rosacea Treatment Mode of Administration Outlook (Revenue, USD Million, 2014 - 2025) Topical • Oral • Rosacea Treatment Regional Outlook (Revenue, USD Million, 2014 - 2025) Follow Us:

  3. North America • oU.S. oCanada Europe • oU.K. oGermany Latin America • oBrazil oMexico Asia Pacific • oJapan oChina oIndia Middle East & Africa • oSouth Africa Table of Content Chapter 1 Methodology and Scope 1.1 Research Methodology 1.2 Research Scope and Assumptions 1.3 List of Tables Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Market Variables, Trends & Scope 3.1 Market Segmentation Chapter 4 Market Definitions 4.1 Disease Primer and Epidemiology 4.2 Market Segmentation Chapter 5 Industry Outlook 5.1 Market Driver Analysis Follow Us:

  4. 5.1.1 Surging geriatric population 5.1.2 Advanced formulations of drugs 5.1.3 Shift towards combination therapies 5.1.4 Increase in disease prevalence 5.2 Market Restraint Analysis 5.2.1 Generic penetration 5.2.2 Off-label usage of drugs Chapter 6 Business Environment Analysis 6.1 SWOT Analysis; By factor (political & legal, economic and technological) 6.2 Porter’s Five Forces Analysis 6.3 Pipeline Analysis Chapter 7 Drug Class Business Analysis 7.1 Rosacea Treatment market: Drug Class Movement Analysis 7.2 Antibiotics 7.2.1 Antibiotics market estimates and forecast, 2014 - 2025 7.3 Alpha Agonists 7.3.1 Alpha agonists market estimates and forecast, 2014 - 2025 7.4 Retinoids 7.4.1 Retinoids market estimates and forecast, 2014 - 2025 7.5 Corticosteroids 7.5.1 Corticosteroids market estimates and forecast, 2014 - 2025 7.6 Immunosuppressants 7.6.1 Immunosuppressants market estimates and forecast, 2014 - 2025 7.7 Antihypertensive Agents 7.7.1 Antihypertensive agents market estimates and forecast, 2014 - 2025 7.8 Others 7.8.1 Others market estimates and forecast, 2014 - 2025 Chapter 8 Mode Of Administration Business Analysis 8.1 Rosacea Treatment market: Mode of Administration Movement Analysis 8.2 Topical 8.2.1 Topical market estimates and forecast, 2014 - 2025 8.3 Oral 8.3.1 Oral market estimates and forecast, 2014 - 2025 Chapter 9 Regional Business Analysis Follow Us:

  5. 9.1 Rosacea Treatment Market: Regional Movement Analysis 9.2 North America 9.2.1 North America market estimates and forecast, 2014 - 2025 9.2.2 U.S. 9.2.2.1 U.S. market estimates and forecast, 2014 - 2025 9.2.3 Canada 9.2.3.1 Canada market estimates and forecast, 2014 - 2025 9.3 Europe 9.3.1 Europe market estimates and forecast, 2014 - 2025 9.3.2 Germany 9.3.3 Germany market estimates and forecast, 2014 - 2025 9.3.4 U.K. 9.3.5 U.K. market estimates and forecast, 2014 - 2025 9.4 Asia-Pacific 9.4.1 Asia-Pacific market estimates and forecast, 2014 - 2025 9.4.2 Japan 9.4.2.1 Japan market estimates and forecast, 2014 - 2025 9.4.3 China 9.4.3.1 China market estimates and forecast, 2014 - 2025 9.4.4 India 9.4.4.1 India market estimates and forecast, 2014 - 2025 9.5 Latin America 9.5.1 Latin America market estimates and forecast, 2014 - 2025 9.5.2 Brazil 9.5.2.1 Brazil market estimates and forecast, 2014 - 2025 9.5.3 Mexico 9.5.3.1 Market estimates and forecast, 2014 - 2025 9.6 Middle East and Africa 9.6.1 Middle-East and Africa market estimates and forecast, 2014 - 2025 9.6.2 South Africa 9.6.3 South Africa market estimates and forecast, 2014 - 2025 Chapter 10 Company Profile 10.1 Company Profiles 10.1.1 Nestlé S.A. Follow Us:

  6. 10.1.1.1 Company Overview 10.1.1.2 Financial Performance 10.1.1.3 Product Benchmarking 10.1.1.4 Strategic Initiatives 10.1.2 Allergan Plc 10.1.2.1 Company Overview 10.1.2.2 Financial Performance 10.1.2.3 Product Benchmarking 10.1.2.4 Strategic Initiatives 10.1.3 Bayer Schering AG 10.1.3.1 Company Overview 10.1.3.2 Financial Performance 10.1.3.3 Product Benchmarking 10.1.3.4 Strategic Initiatives 10.1.4 Bausch Health Companies Inc. 10.1.4.1 Company Overview 10.1.4.2 Financial Performance 10.1.4.3 Product Benchmarking 10.1.4.4 Strategic Initiatives 10.1.5 Foamix Pharmaceuticals 10.1.5.1 Company Overview 10.1.5.2 Financial Performance 10.1.5.3 Product Benchmarking 10.1.5.4 Strategic Initiatives 10.1.6 Sol-Gel Technologies 10.1.6.1 Company Overview 10.1.6.2 Financial Performance 10.1.6.3 Product Benchmarking 10.1.6.4 Strategic Initiatives Follow Us:

  7. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related